[
  {
    "ts": "2026-01-02T12:53:10+00:00",
    "headline": "What Makes Eli Lilly And Co. (LLY) a Worthy Holding?",
    "summary": "Alpha Wealth Funds, LLC, an investment management company, released its Q3 2025 letter for the “Insiders Fund”. A copy of the letter can be downloaded here. The fund returned 4.96% in September, bringing the YTD returns to 21.37%. This compares to the benchmark, S&P 500 September return of 3.65% and the year-to-date return through September […]",
    "url": "https://finance.yahoo.com/news/makes-eli-lilly-co-lly-125310707.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "539d181b-998d-33ea-9b7c-87fd7b787039",
      "content": {
        "id": "539d181b-998d-33ea-9b7c-87fd7b787039",
        "contentType": "STORY",
        "title": "What Makes Eli Lilly And Co. (LLY) a Worthy Holding?",
        "description": "",
        "summary": "Alpha Wealth Funds, LLC, an investment management company, released its Q3 2025 letter for the “Insiders Fund”. A copy of the letter can be downloaded here. The fund returned 4.96% in September, bringing the YTD returns to 21.37%. This compares to the benchmark, S&P 500 September return of 3.65% and the year-to-date return through September […]",
        "pubDate": "2026-01-02T12:53:10Z",
        "displayTime": "2026-01-02T12:53:10Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/a9fb68fd7057548f7ce119cac6a87e1c",
          "originalWidth": 768,
          "originalHeight": 430,
          "caption": "Was Jim Cramer Right About Eli Lilly and Company (LLY)?",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/DFQyzS.MgxX7FGup4wuuQQ--~B/aD00MzA7dz03Njg7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/a9fb68fd7057548f7ce119cac6a87e1c.cf.webp",
              "width": 768,
              "height": 430,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Lop4Pg7FGZ0GE4bKJLODDA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/a9fb68fd7057548f7ce119cac6a87e1c.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/makes-eli-lilly-co-lly-125310707.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/makes-eli-lilly-co-lly-125310707.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-02T13:34:38+00:00",
    "headline": "Equities to Get Boost From Robust Earnings in 2026 But Near-Term Fed Path Uncertain, Analysts Say",
    "summary": "US equity markets are poised to get a boost from strong corporate earnings this year as spending con",
    "url": "https://finance.yahoo.com/news/equities-boost-robust-earnings-2026-133438956.html",
    "source": "MT Newswires",
    "provider": "yfinance",
    "raw": {
      "id": "11fc1eab-d54d-3a9d-a538-886fa12cf048",
      "content": {
        "id": "11fc1eab-d54d-3a9d-a538-886fa12cf048",
        "contentType": "STORY",
        "title": "Equities to Get Boost From Robust Earnings in 2026 But Near-Term Fed Path Uncertain, Analysts Say",
        "description": "",
        "summary": "US equity markets are poised to get a boost from strong corporate earnings this year as spending con",
        "pubDate": "2026-01-02T13:34:38Z",
        "displayTime": "2026-01-02T13:34:38Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/mt_newswires_premium_news_706/6bb7c2fb42cf32701d68de803e00b0ef",
          "originalWidth": 1024,
          "originalHeight": 683,
          "caption": "wallstreetsign.jpg - Shutterstock",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/lI5cIjBjU5eubUz1M.E4aA--~B/aD02ODM7dz0xMDI0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/mt_newswires_premium_news_706/6bb7c2fb42cf32701d68de803e00b0ef.cf.webp",
              "width": 1024,
              "height": 683,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/pEfwAFBugUgkoc.pTwU_Jw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/mt_newswires_premium_news_706/6bb7c2fb42cf32701d68de803e00b0ef.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "MT Newswires",
          "url": "https://www.mtnewswires.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/equities-boost-robust-earnings-2026-133438956.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/equities-boost-robust-earnings-2026-133438956.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "^GSPC"
            },
            {
              "symbol": "^DJI"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": true,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-02T14:01:00+00:00",
    "headline": "Here's How VKTX's Obesity Drug Is Moving Quickly Through Phase III",
    "summary": "Viking Therapeutics' obesity drug VK2735 is racing through phase III, with one pivotal study fully enrolled just months after launch.",
    "url": "https://finance.yahoo.com/news/heres-vktxs-obesity-drug-moving-140100688.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "1c4d6aa0-6a75-3ae2-8c94-9103ce58aed9",
      "content": {
        "id": "1c4d6aa0-6a75-3ae2-8c94-9103ce58aed9",
        "contentType": "STORY",
        "title": "Here's How VKTX's Obesity Drug Is Moving Quickly Through Phase III",
        "description": "",
        "summary": "Viking Therapeutics' obesity drug VK2735 is racing through phase III, with one pivotal study fully enrolled just months after launch.",
        "pubDate": "2026-01-02T14:01:00Z",
        "displayTime": "2026-01-02T14:01:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/9c1d11cd27737fac4805145de6e5eee0",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/TNBAnrhWOnvvvNSvMEIuFg--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/9c1d11cd27737fac4805145de6e5eee0.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/rP7ZEHNft_Sb_FB9M.3i3w--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/9c1d11cd27737fac4805145de6e5eee0.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/heres-vktxs-obesity-drug-moving-140100688.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/heres-vktxs-obesity-drug-moving-140100688.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "VKTX"
            },
            {
              "symbol": "NONOF"
            },
            {
              "symbol": "NVO"
            },
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]